Poly(α-hydroxy acids): Carriers for bone morphogenetic proteins

Biomaterials

Volumn 17, Issue 2, 1996, Pages 187-194

  Hollinger, Jeffrey O ^a   Leong, Kam ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Bone morphogenetic protein; Bone repair; Poly( hydroxy acids)

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HYDROXYACID;

ARTICLE; BONE REMODELING; CELL INTERACTION; CELLULAR DISTRIBUTION; CRANIOFACIAL SURGERY; FRACTURE NONUNION; HUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; WOUND;

EID: 0030034285     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)85763-2     Document Type: Article

References (101)

1. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg 1978; 60B: 150-162.
2. Brighton C. Principles of fracture healing. Part I. The biology of fracture repair. Instructional Course 1984; 32: 60.
3. Reddi A. Extracellular matrix and development. In: Piez KA, Reddi AH, eds. Extracellular Matrix Biochemistry. New York: Elsevier, 1984: 375-412.
4. Simmons DJ. Fracture healing perspectives. Clin Orthop Rel Res 1985; 200: 100-113.
5. Brighton CT, Hunt RM. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg 1991; 73A: 832-847.
6. Bolander ME. Regulation of fracture repair by growth factors. Proc Soc Exper Biol Med 1992; 200: 165-170.
7. Vukicevic S, Paralkar VM, Reddi AH. Extracellular matrix and bone morphogenetic proteins in cartilage and bone development and repair. Adv Mol Cell Biol 1993; 6: 207-224.
8. Lane J, Sandhu H. Current approaches to experimental bone grafting. Orthop Clin North Am 1987; 18: 213-225.
9. Horowitz MC, Friedlaender GE. Induction of specific T-cell responsiveness to allogenic bone. J Bone Joint Surg 1991; 73A: 1157-1168.
10. Gregory CF. The current status of bone and joint transplants. Clin Orthop Rel Res 1972; 87: 156-166.
11. Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg 1991; 73A: 1123-1142.
12. Goldberg VM, Stevenson S. Natural history of autografts and allografts. Clin Orthop Rel Res 1987; 225: 7-16.
13. Buck BE, Malinin TI. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Rel Res 1989; 240: 129-136.
14. Buck BE, Resnick L, Shah SM. Human immunodeficiency virus cultured from human bone. Clin Orthop Rel Res 1990; 251: 249-252.
15. Asselmeier MA, Caspari RB, Bottenfield S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med 1993; 21: 170-175.
16. Hollinger JO. Factors for osseous repair and delivery: Part 1. J Craniofac Surg 1993; 4: 115-121.
17. Madri JA, Basson MD. Extracellular matrix-cell interactions: dynamic modulators of cell, tissues, and organisms structure and function. Lab Invest 1992; 66: 519-521.
18. Raghow R. The role of extracellular matrix in post-inflammatory wound healing and fibrosis. FASEB J 1994; 8: 823-831.
19. Reddi AH, Anderson WA. Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J Cell Biol 1976; 69: 557-572.
20. Triffitt JT. Initiation and enhancement of bone formation. Acta Orthop Scand 1987; 58: 673-684.
21. Bernick S, Paule W, Ertl D, Nishimoto SK, Nimni ME. Cellular events associated with the induction of bone by demineralized bone. J Orthop Res 1989; 7: 1-11.
22. Sawyer JR, Myers MA, Rosier RN, Puzas JE. Heterotopic ossification: clinical and cellular aspects. Calcif Tissue Int 1991; 49: 208-215.
23. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-899.
24. Urist MR, Silverman MF, Buring K, Dubuc FL, Rosenburg JM. The bone induction principle. Clin Orthop Rel Res 1967; 53: 243.
25. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971; 50: 1392-1406.
26. Wozney JM. Bone morphogenetic proteins. Prog Growth Factors 1989; 1: 267-280.
27. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992; 32: 160-167.
28. Kingsley D. What do BMPs do in mammals? Clues from the mouse short-ear mutation. TIG 1994; 10: 16-21.
29. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-146.
30. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types with affinity chromatography and heparin sepharose. J Biol Chem 1986; 261: 12 665-12 674.
31. Hauschka PV. Growth factor effects in bone. In: Hall BK, ed. The Osteoblast and Osteocyte. West Caldwell, NJ: The Telfor Press, Inc., 1990: 103-170.
32. Chu CC. The degradation and biocompatibility of suture materials. In: Williams DF, ed. CRC Critical Reviews in Biocompatibility. Boca Raton, FL: CRC Press, 1985: 261-322.
33. Hollinger JO, Battistone GC. Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin Orthop Rel Res 1986; 207: 290-305.
34. Ron E, Langer R. Erodible systems. In: Kydonieus A, ed. Treatise on Controlled Drug Delivery. Fundamentals, Optimization, Applications. New York: Marcel Dekker, 1992: 199-224.
35. Nieuwenhuis J. Synthesis of polylactides, polyglycolides and their copolymers. Clin Mater 1992; 10: 59-67.
36. Morrison RT, Boyd RN. Organic Chemistry. Boston: Allyn and Bacon, 1980.
37. Eliel EL. Stereochemistry of Carbon Compounds. New York: McGraw-Hill, 1962: 1-128.
38. Brandt BB, Waters GM, Rispler MJ, Kline ES. D-and L-Lactate catabolism to carbon dioxide in rat tissues. Proc Soc Exp Biol Med 1984; 175: 328-335.
39. Holland SJ, Tighe BJ, Gould PL. Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. J Contr Rel 1986; 4: 155-180.
40. Pistner H, Bemdox DR, Muhling J, Reuther JF. Poly(L-lactide): a long-term degradation study in vivo. Part 3. Analytical characterization. Biomaterials 1993; 14: 291-304.
41. Vert M, Li S, Garreau H. New insights on the degradation of bioresorbable polymeric devices based on lactic and glycolic acids. Clin Mater 1992; 10: 3-8.
42. Vert M, Chabot F, Leray J, Christel P. Biodegradable polyesters for bone surgery. Makromol Chem Suppl 1981; 5: 30-36.
43. Suganuma J, Alexander H. Biological response of intramedullary bone to poly-L-lactic acid. J Appl Biomater 1993; 4: 13-27.
44. Reddi AH. Bone matrix in the solid state: Geometric influence on differentiation of fibroblasts. Adv Biol Med Phys 1974; 15: 1.
45. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacantu JP, Langer R. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res 1993; 27: 183-189.
46. Mikos AG, Lyman MD, Freed LE, Langer R. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994; 15: 55-58.
47. Li S, Garreua H, Vert M. Structure-property relationships in the case of the degradation of massive aliphatic poly(α-hydroxy-acids) in aqueous media. Part 2: Degradation of lactide-glycolide PLA37.5;GA25 and PLA75:GA25 Poly(DL-lactic acid). J Mater Sci Mater Med 1990; 1: 131-139.
48. Li S, Garreua H, Vert M. Structure-property relationships in the case of the degradation of massive aliphatic poly(α-hydroxy-acids) in aqueous media. Part 1: Poly(DL-lactic acid). J Mater Sci Mater Med 1990; 1: 123-130.
49. Li S, Garreua H, Vert M. Structure-property relationships in the case of the degradation of massive aliphatic poly(α-hydroxy-acids) in aqueous media. Part 3: Influence of the morphology of poly(L-lactic acid). J Mater Sci Mater Med 1990; 1: 198-206.
50. Tabata Y, Ikado Y. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/ glycolic acid homo-and copolymers. J Biomed Mater Res 1988; 22: 837-858.
51. Lam KH, Schakenraad JM, Esselbrugge H, Feijen J, Nieuwenhuis P. The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability. J Biomed Mater Res 1993; 27: 1569-1577.
52. Verheyen CCPM, De Wijn JR, Van Blitterwijk CA, Rozing PM, De Groot K. Examination of efferent lymph nodes after 2 years of transcortical implantation of poly(L-lactide) containing plugs: a case report. J Biomed Mater Res 1993; 27: 1115-1118.
53. Leroux JC, Gravel P, Balant L et al. Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles. J Biomed Mater Res 1994; 28: 471-481.
54. Yamaguchi K, Anderson J. In vivo biocompatibility studies of medisorb 65/35 D,L-lactide/glycolide copolymer microspheres. J Contr Rel 1993; 24: 81-93.
55. Bostman O, Hirvensalo E, Makinen J, Rokkanen P. Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg 1990; 72B: 592-596.
56. Bostman O. Absorbable implants for fixation of fractures. J Bone Joint Surg 1991; 73A: 148-153.
57. Bostman O, Paivarinta U, Patio E et al. Absorbable polyglycolide screws in internal fixation of femoral osteotomies in rabbits. Acta Orthop Scand 1991; 62: 587-591.
58. Bergsma EJ, Rozema FR, Bos RRM, De Bruijn WC. Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for fixation of unstable zygomatic fractures. J Oral Maxillofac Surg 1993; 51: 666-670.
59. Bostman O. Intense granulomatous inflammatory lesions associated with absorbable internal fixation devices made of polyglycolide in ankle fractures. Clin Orthop Rel Res 1992; 778: 178-199.
60. Nakamura T, Shimizo Y, Okumura N, Matsui T, Hyon S, Shimamoto T. Tumorigenicity of poly-L-lactide (PLLA) plates compared with medical-grade polyethylene. J Biomed Mater Res 1994; 28: 17-25.
61. Schoen F. Biomaterials-associated infection, neoplasia, and calcification. Trans Am Soc Artif Intern Organs 1987; XXXIII: 8-23.
62. Schoen FJ. Biomaterial-associated tumorigenesis. In: Ratner B, ed. Biomaterials Science: An Introductory Text. Orlando, FL: Academic Press, 1990.
63. Bos R, Boering G, Rozema F et al. Degradation of and tissue reaction to biodegradable poly(L-lactide) for use as internal fixation for fractures: a study in rats. Biomaterials 1991; 12: 32-36.
64. Campbell JP, Edsberg L, Meyer AE. Polylactide inhibition of carcinoma cell growth in vitro. J Oral Maxillofac Surg 1994; 52: 49-51.
65. Devereux DF, O'Connell SM, Liesch JB, Weinstein M, Robertson FM. Induction of leukocyte activation by meshes surgically implanted in the peritoneal cavity. Am J Surg 1991; 162: 243-246.
66. Hollinger JO, Schmitz JP, Mark DE, Seyfer AE. Osseous wound healing with xenogeneic bone implants with a biodegradable carrier. Surgery 1990; 107: 50-54.
67. Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg 1991; 73A: 751-763.
68. Toriumi DM, Larrabee WFJ, Walike JW, Millay DJ, Eisele DW. Demineralized bone. Implant resorption with long-term follow-up. Arch Otolaryngol Head Neck Surg 1990; 116: 676-680.
69. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg 1992; 74A: 659-671.
70. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub R, Ron E. Recombinant bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomies defects in rat. J Biomed Mater Res 1994; 28: 1127-1138.
71. Kleinschmidt J, Hollinger JO, Quigley N, Marden LJ. A multiphase system implant for regenerating calvaria. J Plast Reconstr Surg 1993; 91: 581-588.
72. Hollinger JO. Factors for osseous repair and delivery: Part 11. J Craniofac Surg 1993; 4: 135-141.
73. Reddi AH, Sampath TK, Hand AR. Biosynthesis of extracellular matrix in bone: approaches and prospects. In: Veis A, ed. The Chemistry and Biology of Mineralized Connective Tissue. NY: Elsevier North Holland, 1981: 417-426.
74. Hulbert S, Young F, Mathews R, Klawitter J, Talbert C, Stelling F. Potential of ceramics materials as permanently implantable skeletal prosthesis. J Biomed Mater Res 1970; 4: 433-442.
75. Klawitter J, Hulbert S. Application of porous ceramics for the attachment of load bearing internal orthopedic applications. J Biomed Res Symp No. 2 (Part 1) 1971; 161-229.
76. Klawitter J, Bagwell J, Weinstein A, Sauer B, Pruitt J. An evaluation of bone ingrowth into porous high density polyethylene. J Biomed Mater Res 1976; 10: 311-323.
77. Spector M, Flemming WR, Kreutner A. Bone ingrowth into porous high density polyethylene. J Biomed Mater Res 1976; 7: 595-603.
78. Spector M, Harmon S, Kreutner A. Characteristics of tissue ingrowth into porous proplast and porous polyethylene implants in bone. J Biomed Mater Res 1979; 13: 677-692.
79. Hollinger JO, Schmitz JP, Mizgala JW, Hassler C. An evaluation of two configurations of tricalcium phosphate for treating craniotomies. J Biomed Mater Res 1989; 23: 17-29.
80. Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. J Plast Reconstr Surg 1979; 63: 626-633.
81. Holmes RE, Bucholz RW, Mooney V. Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects. J Bone Joint Surg 1986; 68A: 904-911.
82. Lewis D. Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin M, Langer R, ed. Biodegradable Polymers as Drug Delivery Systems. New York: Marcel Dekker, 1990: 1-42.
83. Robinson B, Hollinger JO, Szachowicz E, Brekke J. Calvarial bone repair with porous D,L-polylactide. Otolaryngol Head Neck Surg 1995; 112: 707-713.
84. Wozney JM, Rosen V, Celeste AJ et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534.
85. Özkaynak E, Rueger DC, Drier EA et al. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. J EMBO 1990; 9: 2085-2093.
86. Özkaynak E, Schnegelsberg PN, Jin DF et al. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed in early embryogensis. J Biol Chem 1992; 267: 25 220-25 227.
87. Kenley R, Yim K, Abrams J et al. Biotechnology and bone graft substitutes. Pharmacol Res 1993; 10: 1393-1401.
88. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger J. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant bone morphogenetic protein 2 (rhBMP-2). J Biomed Mater Res 1994; 28: 1139-1147.
89. Toriumi DM, Kotler HS. Luxunberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991; 117: 1101-1112.
90. Mayer MM, Hollinger JO. Repair of alveolar clefts in dogs with recombinant bone morphogenetic protein and poly(α-hydroxy acid). J Plast Reconstr Surg (in press).
91. Gerhart TNK Kirker-Head CA, Kriz MJ et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein (rhBMP-2). Clin Orthop Rel Res 1993; 293: 317-326.
92. Cook SD, Baffes GC, Wolfe MW, Sampath K, Rueger DC, Whitecloud TS. The effect of human recombinant osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg 1994; 76A: 827-838.
93. Hollinger JO, Zegzula D, Buck D, Smith J, Wozney J. Reconstruction and regeneration of critical-sized segmental defects in radii of rhesus nonhuman primates. In preparation.
94. Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J. The human immune response to reconstituted bovine collagen. J Immunol 1986; 136: 877-882.
95. DeLustro F, Dasch J, Keefe J, Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop Rel Res 1990; 260: 263-279.
96. van Luyn MJA, van Wachem PB, Olde Damink LHH, Dikstra PJ, Feijen J, Nieuwenhuis P. Secondary cytotoxicity of cross-linked dermal sheep collagens during repeated exposure to human fibroblasts. Biomaterials 1992; 13: 1017-1024.
97. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 1981; 78: 7599-7603.
98. Reddi AH. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 1992; 4: 850-855.
99. Lin CQ, Bissel MJ, Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 1993; 7: 737-743.
100. Paralkar VM, Nandedkar AKN, Pointer RH, Kleinman HK, Reddi AH. Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem 1990; 265: 17 281-17 284.
101. Hollinger JO, Jamiolkowski D, Shalaby SW. Poly(α-hydroxy acids) and bone repair. In: Hollinger JO, ed. Biomedical Applications of Synthetic Biodegradable Polymers. Boca Raton, FL: CRC Press, 1995: 197-222.